Ferrer's Jorge Gonzalez on Predictive Toxicology Strategy
It is very important to capitalise on innovative developments and implement the latest in-vitro and in-silico models to address the continual challenge of in-vitro and in-vivo extrapolation. In this Pharma IQ interview we are joined by Jorge I. González Borroto, senior toxicologist for pharmacology and safety at Ferrer International.
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.